search.noResults

search.searching

saml.title
dataCollection.invalidEmail
note.createNoteMessage

search.noResults

search.searching

orderForm.title

orderForm.productCode
orderForm.description
orderForm.quantity
orderForm.itemPrice
orderForm.price
orderForm.totalPrice
orderForm.deliveryDetails.billingAddress
orderForm.deliveryDetails.deliveryAddress
orderForm.noItems
Laser & photonics


specialised optomechanical hardware for the multi- spectral sensor. Wasatch Photonics offers highly sensitive Raman spectrometers and systems that can be adapted for OEM use. Its integrated Raman systems for 785, 830 and 1,064nm include a Raman spectrometer with a spectral resolution of <10cm−1, laser and sampling optics. These modules are being integrated into point-of-care testing devices for non- invasive and serum-based diagnostics.


A combination of technologies The development and production of optical biosensors and POC devices requires a combination of expertise from many different fields. For example, a typical spectroscopic unit requires the combination of fibre optics, electronics and hermetic sealing for an integrated system. The ecosystem is complex and requires significant collaboration between diverse groups from component manufactures to system integrators and end-users. To ensure the innovation behind these combined devices continues, the EU supported the creation of Europe’s first pre- commercial production line for photonics-based medical diagnostics. The EU project or Pilot Line, named MedPhab, offers a wide portfolio of photonics technologies: fibre optics, micro-optics, integrated circuits and active components. The modular


technology approach allows MedPhab to simplify the development of diverse systems. The MedPhab pilot production line accelerates the commercialisation of measurement, monitoring, and diagnostic devices and treatment instruments. Seamless operation between ISO13485-certified companies and RTOs makes MedPhab a single-entry point that can serve companies working at different technology readiness levels. Furthermore, the project operates within medical domain setting requirements, which considerably accelerates the regulatory approval process.


MedPhab has already demonstrated some of its capabilities by setting up a fully automated, high- volume manufacturing process for highly sensitive plasmonic-fluidic sensors for molecular diagnostics. Companies interested in manufacturing, testing, validating or upscaling new photonics technologies for medical diagnostics can contact MedPhab directly or apply for the Demo Cases Open Call – a new programme set up to help fund chosen products. Companies developing POCT technology, looking for new partners or suppliers of photonics technologies, or just interested in learning more about the potential they have should not miss the upcoming EPIC Online Technology Meeting on Medical Devices on 6 December 2021 at 3pm CET. ●


Medical Device Developments / www.nsmedicaldevices.com


73


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72  |  Page 73  |  Page 74  |  Page 75  |  Page 76  |  Page 77  |  Page 78  |  Page 79  |  Page 80  |  Page 81  |  Page 82  |  Page 83  |  Page 84  |  Page 85  |  Page 86  |  Page 87  |  Page 88  |  Page 89  |  Page 90  |  Page 91  |  Page 92  |  Page 93  |  Page 94  |  Page 95  |  Page 96  |  Page 97  |  Page 98  |  Page 99  |  Page 100  |  Page 101  |  Page 102  |  Page 103  |  Page 104  |  Page 105  |  Page 106  |  Page 107  |  Page 108  |  Page 109  |  Page 110  |  Page 111  |  Page 112  |  Page 113  |  Page 114  |  Page 115  |  Page 116  |  Page 117  |  Page 118  |  Page 119  |  Page 120  |  Page 121  |  Page 122  |  Page 123  |  Page 124  |  Page 125  |  Page 126  |  Page 127  |  Page 128  |  Page 129  |  Page 130  |  Page 131  |  Page 132  |  Page 133  |  Page 134  |  Page 135  |  Page 136  |  Page 137  |  Page 138  |  Page 139  |  Page 140  |  Page 141  |  Page 142  |  Page 143  |  Page 144  |  Page 145  |  Page 146  |  Page 147  |  Page 148  |  Page 149  |  Page 150  |  Page 151  |  Page 152  |  Page 153  |  Page 154  |  Page 155  |  Page 156  |  Page 157  |  Page 158  |  Page 159  |  Page 160  |  Page 161  |  Page 162  |  Page 163  |  Page 164  |  Page 165  |  Page 166  |  Page 167  |  Page 168  |  Page 169  |  Page 170